The retrospective series quote a local control rate of 85-90% at one year and the current NCCN guidelines list this as an option following surgery for limited mets (level 2B v. level 1 evidence for WBRT). Now that ASTRO is advocating against adjuvant whole brain radiation therapy following SRS for limited brain metastases (in the Choose Wisely Campaign), do you think a push towards postop SRS is next?